Citius Oncology director Peri files Form 3

CITIUS ONCOLOGY, INC. director Jonathan Peri filed an initial Form 3 reporting his equity position in the company.

Rhea-AI Filing Summary

CITIUS ONCOLOGY, INC. director Jonathan Peri filed an initial Form 3 reporting his equity position in the company. The filing lists a holding entry for Common Stock with 0 shares reported as directly owned following the reported position.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Peri Jonathan

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

Key Figures

Common Stock directly owned: 0.0000 shares Holding entries: 1 Net buy/sell shares: 0

3 metrics

Common Stock directly owned 0.0000 shares Total shares following reported position

Holding entries 1 Number of holding entries in transaction summary

Net buy/sell shares 0 Net buy/sell direction reported as neutral

Key Terms

Common Stock, beneficial ownership, direct or indirect

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

beneficial ownership financial

"initial statement of beneficial ownership of securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

direct or indirect financial

"direct_or_indirect: "D" indicates direct ownership type"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Jonathan Peri’s Form 3 filing for CTOR report?

The Form 3 for CITIUS ONCOLOGY, INC. (CTOR) reports Jonathan Peri’s initial beneficial ownership, listing a holding entry in Common Stock with 0 shares directly owned following the reported position.

What position does Jonathan Peri hold at CITIUS ONCOLOGY, INC. (CTOR)?

The Form 3 indicates that Jonathan Peri is a director of CITIUS ONCOLOGY, INC. He is not reported as an officer or a ten percent owner in this filing.

How many CTOR common shares does Jonathan Peri report owning on Form 3?

The Form 3 reports that Jonathan Peri has 0.0000 shares of Common Stock directly owned following the reported position. No purchase, sale, or acquisition transactions are listed in the filing.

Does the CTOR Form 3 for Jonathan Peri show any recent insider transactions?

No. The Form 3 presents a holding entry only, with no indicated purchase, sale, or other transaction codes. It simply establishes Jonathan Peri’s beneficial ownership position as of the reported date.

Are there any derivative securities reported for Jonathan Peri in the CTOR Form 3?

No derivative securities are listed. The derivativeSummary is empty and there are no derivative transactions reported, indicating only a common stock holding entry in this Form 3.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 05:58 PM Accepted by SEC EDGAR 08/14/2026 - 05:57 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Peri Jonathan

(Last) (First) (Middle)

C/O CITIUS ONCOLOGY, INC.

11 COMMERCE DRIVE, 1ST FLOOR

(Street)

CRANFORD NEW JERSEY 07016

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/10/2026

3. Issuer Name and Ticker or Trading Symbol
CITIUS ONCOLOGY, INC. [ CTOR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Alexander M. Donaldson, by Power of Attorney	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)